Disease-Based Limitations On Compulsory Licenses
Appearing in RESEARCH HANDBOOK ON INTELLECTUAL APROPERTY LAW AND THE WTO (Carlos Correa, ed., Edward Elgar, pending 2009).)
Compulsory licensure is one of the flexibilities retained under TRIPS to permit countries to support public health while granting pharmaceutical patents. The United States Government appears to take the position that compulsory licensure and other TRIPS flexibilities must be limited to certain infectious diseases, namely AIDS, tuberculosis, and malaria. These proposed limitations are not supported by the text of Articles 31 and 31bis of TRIPS or by the negotiating history of the Agreement. Introducing disease-based limitations would be unwise, as the developing world is undergoing a demographic transition, with increasing shares of its disease burden coming from non-infectious diseases. Public health calls for retaining TRIPS flexibilities in all categories of human need.
Keywords: compulsory license, TRIPS, pharmaceuticals, USTR, disease
SSRN Accepted Paper Series
Size: 292 KB
Adobe Acrobat Reader v3.01 or greater is required to view this paper.
Kevin Outterson, ""Disease-Based Limitations on Compulsory Licenses Under Articles 31 and 31bis," Appearing in RESEARCH HANDBOOK ON INTELLECTUAL PROPERTY LAW AND THE WTO (Carlos Correa, ed., Edward Elgar, pending 2009).
Kevin Outterson Contact Information
Email address: email@example.com
Office Phone: (617) 353-3135